← Evidence map

ArticleCNS drugs2016

The Cost Effectiveness of Nalmefene for Reduction of Alcohol Consumption in Alcohol-Dependent Patients with High or Very High Drinking-Risk Levels from a UK Societal Perspective.

Thor-Henrik Brodtkorb et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
2024
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 26879458